Navigation Links
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
Date:12/29/2008

ent of Veterans Affairs (VA) failed to demonstrate the claims by the VA that the stem cells injected after CCG-TH30 or CCG-TH35 localized in the desired target organ. As a result, CellCyte expects that it will need to complete potentially significant amounts of additional research to confirm if such claims can be upheld. CellCyte licensed the technology from the VA in 2005. CellCyte plans to pursue industry partners to collaboratively assist in executing some or all of the additional research. CellCyte will announce more information as the negotiations of each of these collaborations are completed.

About CellCyte Genetics

CellCyte Genetics is a biotechnology company with two business segments: a device division and the development of therapeutic products. The Company's device division is focused on technology for the efficient and cost-effective expansion and maintenance of different cell types for research as well as clinical applications. The therapeutics division is engaged in the discovery, development and commercialization of stem cell enabling therapeutic products to allow more efficient delivery of adult stem cells to diseased organs, such as the heart after a heart attack. The goal of these therapies is to increase the number of stem cells delivered to a damaged organ, which is expected to markedly increase organ healing and functional restoration.

For further information see: www.cellcyte.com.

Symbol: OTCBB - CCYG; Frankfurt/Berlin Symbol - LK6 WKN. No.: A0MLCV.

Safe Harbor Statement

THIS NEWS RELEASE CONTAINS "FORWARD-LOOKING STATEMENTS", AS THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. STATEMENTS IN THIS NEWS RELEASE, WHICH ARE NOT PURELY HISTORICAL, ARE FORWARD-LOOKING STATEMENTS AND INC
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development
2. Beta Release of a New Genetics Website- ItRunsInMyFamily.com
3. PTSD Risk Rooted in Stress and Genetics
4. Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nations Premier High School Science Competition
5. Understanding donor-recipient genetics could decrease early kidney transplant complications
6. Lung Cancer Genetics Different in Black Patients: Study
7. Genetics of aging and cancer resistance
8. Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery
9. New technique to study the genetics of breast cancer
10. Know the Myths and Facts About Family Health History: American College of Medical Genetics
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Roughly four in 10 uninsured patients who have been ... not have the lung disease, a small new study ... on an evaluation of symptoms, rather than by means ... spirometry, which shows how well a patient,s lungs are ... exhale and how long that takes. The ...
(Date:5/22/2013)... May 22, 2013 Teams who focus ... improvements use the new Do-Done StepTracker whiteboard as a ... the Do-Done board to display the current status of ... production cells and departments is listed down the side ... start a project, the squares are filled with yellow ...
(Date:5/22/2013)... John Mathews from the University of Melbourne said this ... the undoubted benefits from CT scans in diagnosing and ... the British Medical Journal today and involved ... and the International Agency for Research on Cancer in ... were very useful in providing detailed three dimensional pictures ...
(Date:5/22/2013)... than 40 percent of patients being treated for ... have the disease, researchers found after evaluating the ... chronic obstructive pulmonary disease. , "While there have ... there has not been a U.S.-based study that ... Ghattas, MD., MSc, a second-year medical resident ...
(Date:5/22/2013)... The PreDiabetes Center of King of ... Philadelphia Tour de Cure, a premier cycling event that brings ... stopping the spread of diabetes , a chronic disease ... Tour de Cure will take place Saturday, June 1 at ... 30 minutes outside of Philadelphia, between the hours of 7:30 ...
Breaking Medicine News(10 mins):Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Project Managers Organize Manufacturing Projects and Training with the New Steptracker Project Status Magnetic Whiteboards 2Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:Study finds COPD is over-diagnosed among uninsured patients 2Health News:Study finds COPD is over-diagnosed among uninsured patients 3Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3
... EDITOR,S PICK: Possible new approach to treating a life-threatening ... is a life-threatening disease of the blood system. The ... of the protein von Willebrand factor, which promote the ... throughout the body. Current treatments are protracted and associated ...
... -- Breast-feeding may help reduce some long-term negative side ... cancer, according to a new study. The findings ... breast-feeding should be part of routine recommendations for a ... from St. Jude Children,s Research Hospital in Memphis, Tenn. ...
... during cardiovascular surgery, resulting in elevated circulating levels of ... microcirculation and gut wall integrity is unclear. A ... in the World Journal of Gastroenterology addresses ... plasma levels similar to those found during cardiovascular surgery. ...
... conducted at Sahlgrenska University Hospital in Gothenburg and at ... of 18 and 65. Half the group was randomly ... half to maintain their usual lifestyle. Both groups ... group increased their physical activity on their own, but ...
... Lake, N.Y. There is an ongoing battle in the ... -- a race between scientists working to develop a vaccine ... use plague as a weapon. "Governments remain concerned that ... could kill thousands," said Stephen Smiley, a leading plague researcher ...
... 25, 2011) -- A child,s taste preferences begin at home ... say, young kids learn quickly what brands deliver the goods. ... involving two separate experiments, researchers found that salt, sugar and ... children already could equate their taste preferences to brand-name fast-food ...
Cached Medicine News:Health News:JCI table of contents: Jan. 25, 2011 2Health News:JCI table of contents: Jan. 25, 2011 3Health News:JCI table of contents: Jan. 25, 2011 4Health News:JCI table of contents: Jan. 25, 2011 5Health News:JCI table of contents: Jan. 25, 2011 6Health News:JCI table of contents: Jan. 25, 2011 7Health News:JCI table of contents: Jan. 25, 2011 8Health News:Breast-Feeding May Counter Some Effects of Childhood Cancer 2Health News:New discovery could lead to vaccines for plague and bacterial pneumonias 2Health News:Preschool kids know what they like: Salt, sugar and fat 2Health News:Preschool kids know what they like: Salt, sugar and fat 3
(Date:5/22/2013)... WORCESTER, Mass. and TORONTO ... www.generex.com ) (OTCBB: GNBT) today announced three presentations demonstrating ... developed by its wholly-owned subsidiary, Antigen Express, Inc. ( ... annual meeting of the American Society of Clinical Oncology ... from May 31 through June 4, 2013. ...
(Date:5/22/2013)... , 22. Mai 2013  Grifols, ... in Barcelona , Spanien, ... dass eine höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer ... mit Alpha1-Antitrypsinmangel (AAT) auf ein Niveau anhebt, ... bezeichneten Bereichs liegt. ATT-Mangel ist eine lebensbedrohliche, ...
(Date:5/22/2013)... TORONTO , May 22, 2013  Medifocus, Inc. ... John Mon , Chief Operating Officer, will present at ... 30, 2013 in New York City ... presentation is scheduled to begin at 4:00 p.m. EDT and ... webcast, go to:   http://wsw.com/webcast/marcum/mfs.v/   For more ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3
... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... acquire Proteolix, Inc., a privately held biopharmaceutical company ... target the proteasome for the treatment of hematological ... carfilzomib, is a proteasome inhibitor currently in multiple ...
... , EXTON, Pa., Oct. 9 Kensey Nash ... release its earnings results for its first quarter ended September ... 22, 2009. , Joe Kaufmann, President and CEO, ... Thursday, October 22, 2009 at 9:00 A.M. Eastern Time. ...
Cached Medicine Technology:Onyx Pharmaceuticals to Acquire Proteolix, Inc. 2Onyx Pharmaceuticals to Acquire Proteolix, Inc. 3Onyx Pharmaceuticals to Acquire Proteolix, Inc. 4Onyx Pharmaceuticals to Acquire Proteolix, Inc. 5Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 2
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
Medicine Products: